InvestorsHub Logo
Followers 30
Posts 5046
Boards Moderated 0
Alias Born 01/07/2020

Re: Cardiologymd post# 291278

Friday, 08/14/2020 11:40:19 AM

Friday, August 14, 2020 11:40:19 AM

Post# of 425648
Cardio@ Who is talking about prescribing it. It is a product under development/research (a Pipeline product).

Many see Amarin's - missing pipeline - One Drug Company - as maybe the biggest long term weakness.

This is why the possibility of something that might be a 'Product nr. 2' IMO would be great.

Jasbg

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News